Barbara Salami

In this DHCG Disruptive Dose, Mark Bard speaks with Barbara Salami, former Novo Nordisk executive and current CEO of KAINDLY, about transforming patient-centricity from buzzword into operational reality. Salami emphasizes that true patient-centricity requires restructuring how organizations make decisions, moving patient voices from marketing afterthoughts to foundational strategy inputs. She discusses why many pharma efforts fail: they treat patient input as validation rather than discovery, creating theater instead of transformation. Salami offers a pragmatic framework for measuring actual patient-centricity versus claims, emphasizing that it shows up in resource allocation, decision-making authority, and willingness to pivot based on what patients actually need rather than what companies want to sell.